INS and type 1 diabetes mellitus: Despite a few clinical trials showing promising effects of immunosuppressive drugs in preserving residual beta cell function, insulin replacement therapy remains the only widely accepted treatment for people with clinical type 1 diabetes (i.e. stage 3 type 1 diabetes).